CN101843737A - Chinese medicament for treating diabetic feet - Google Patents
Chinese medicament for treating diabetic feet Download PDFInfo
- Publication number
- CN101843737A CN101843737A CN200910237120A CN200910237120A CN101843737A CN 101843737 A CN101843737 A CN 101843737A CN 200910237120 A CN200910237120 A CN 200910237120A CN 200910237120 A CN200910237120 A CN 200910237120A CN 101843737 A CN101843737 A CN 101843737A
- Authority
- CN
- China
- Prior art keywords
- chinese
- parts
- chinese medicine
- chinese medicament
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicament for treating diabetic feet, and belongs to the field of Chinese medicaments for treating surgery diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: amur corktree bark, root of rehmannia, Chinese angelica, largehead atractylodes rhizome, lucid ganoderma, radix pseudo-ginseng, Indian buead and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, and disinhibiting water and percolating dampness, and has the advantages of obvious effect, exact medicinal effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment surgery diseases.
Background technology
The present field of Chinese medicines that is intended to treat diabetic foot, there are some tangible problems: the one, effect is obvious inadequately, the 2nd, it is slower to take effect, so that large quantities of diabeticss are under the situation that the Western medicine antibiotic don't work, lack effective treatment by Chinese herbs again, the state of an illness can not get alleviating for a long time---and lower limb are ice-cold, blood supply is smooth, intermittent limping, lower limb tissue necrosis, acrodynia, fester, and finally have to " amputation " disables.Patient and family members thereof are very dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of diabetic foot, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of diabetic foot adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Cortex Phellodendri 4-30 part Radix Rehmanniae 4-30 part Radix Angelicae Sinensis 4-30 part
Rhizoma Atractylodis Macrocephalae 4-30 part Ganoderma 2-15 part Radix Notoginseng 3-20 part
Poria 4-30 part
The Chinese medicine of this treatment diabetic foot is made by following method:
(1) by above-mentioned weight ratio, Cortex Phellodendri, the Radix Rehmanniae, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Poria are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Rhizoma Atractylodis Macrocephalae air making-up and spleen enlivening in the side, the dampness diuretic; The Poria promoting diuresis to eliminate damp pathogen, the spleen invigorating mind calming, last two flavors are all the medicine of dampness diuretic, and one strong one oozes, and water is wet then outlet, and this is a principal agent; Be aided with Ganoderma, Radix Rehmanniae benefiting QI and nourishing blood, the body resistance strengthening and constitution consolidating, enhancing human body immunity power; Radix Angelicae Sinensis, pseudo-ginseng blood-circulation-invigovating blood-activating analgetic; Compatibility Cortex Phellodendri heat-clearing and toxic substances removing is damp and hot with Qinghua.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the merit of promoting diuresis to eliminate damp pathogen, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Cortex Phellodendri 80 gram Radix Rehmanniae 80 gram Radix Angelicae Sinensis 80 grams
The Rhizoma Atractylodis Macrocephalae 80 kairine sesames 40 gram Radix Notoginseng 60 grams
Poria 80 grams
Weight in accordance with regulations, with conventional water extraction process Cortex Phellodendri, the Radix Rehmanniae, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Poria are extracted, make extractum fine powder 120 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 785 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
The Cortex Phellodendri 160 gram Radix Rehmanniae 160 gram Radix Angelicae Sinensis 160 grams
The Rhizoma Atractylodis Macrocephalae 160 kairine sesames 80 gram Radix Notoginseng 100 grams
Poria 160 grams
By above-mentioned same method, make 1500 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
The Cortex Phellodendri 300 gram Radix Rehmanniae 300 gram Radix Angelicae Sinensis 300 grams
The Rhizoma Atractylodis Macrocephalae 300 kairine sesames 150 gram Radix Notoginseng 200 grams
Poria 300 grams
By above-mentioned same method, make 2857 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
6 parts of 6 parts of Radix Angelicae Sinensis of 6 parts of Radix Rehmanniae of Cortex Phellodendri
4 parts of 3 portions of Radix Notoginseng of 6 portions of Ganodermas of the Rhizoma Atractylodis Macrocephalae
6 parts in Poria
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
20 parts of 20 parts of Radix Angelicae Sinensis of 20 parts of Radix Rehmanniae of Cortex Phellodendri
16 parts of 9 portions of Radix Notoginseng of 20 portions of Ganodermas of the Rhizoma Atractylodis Macrocephalae
20 parts in Poria
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science diabetic foot, through 6 routine clinical observations.Selecting tcm diagnosis diabetic foot acral necrosis is standard: the diabetics emaciated physique, and limb is soft weak; Suffer from limb and send out cold, poor blood circulation; Lower limb pain, intermittent limping; The skin blackout is blue, tissue necrosis; Acra festers, disunion for a long time.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 4 examples, women's 2 examples do not have other serious disease, and the age is 52 years old-79 years old, 64.3 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, on one's body energetically; It is warm to suffer from limb, and blood supply improves; The pain of lower limb and the obviously alleviation of walking lamely; The skin of downright bad blackout changes normal pale skin into; The acra healing of festering grows new meat.
2, effective: body constitution strengthens, on one's body energetically, and acrodynia, the alleviation to some extent of walking lamely, fester.
3, invalid: the disease no change.
During clinical experiment, except that hypoglycemic medicine, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 6 months, is a course of treatment.Instructions of taking: every day 3 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 6 months after, symptom is obviously improved.6 philtrums of clinical experiment, produce effects 3 people, effective 2 people, invalid 1 people, total effective rate 83.3%.
Claims (1)
1. a Chinese medicine for the treatment of diabetic foot adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Cortex Phellodendri 4---30 parts in 30 parts of Radix Rehmanniae 4---30 parts of Radix Angelicae Sinensis 4---
The Rhizoma Atractylodis Macrocephalae 4---20 parts of 30 portions of Ganodermas 2---15 portions of Radix Notoginseng 3---
Poria 4---30 parts
The Chinese medicine of this treatment diabetic foot is made by following method:
(1) by above-mentioned weight ratio, Cortex Phellodendri, the Radix Rehmanniae, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Poria are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910237120A CN101843737A (en) | 2009-11-04 | 2009-11-04 | Chinese medicament for treating diabetic feet |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910237120A CN101843737A (en) | 2009-11-04 | 2009-11-04 | Chinese medicament for treating diabetic feet |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101843737A true CN101843737A (en) | 2010-09-29 |
Family
ID=42768675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910237120A Pending CN101843737A (en) | 2009-11-04 | 2009-11-04 | Chinese medicament for treating diabetic feet |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101843737A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107334940A (en) * | 2017-08-21 | 2017-11-10 | 孙慧博 | Treat Chinese medicine composition of diabetes and preparation method thereof |
-
2009
- 2009-11-04 CN CN200910237120A patent/CN101843737A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107334940A (en) * | 2017-08-21 | 2017-11-10 | 孙慧博 | Treat Chinese medicine composition of diabetes and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101843787B (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
CN101843694B (en) | Chinese medicament for treating chronic hepatitis | |
CN101843804A (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
CN101850071B (en) | Chinese medicament for treating chronic nephritis | |
CN101843738A (en) | Chinese medicament for treating diabetic feet | |
CN101843715A (en) | Chinese medicament for treating diabetic feet | |
CN101850049B (en) | Chinese medicament for treating diabetic foot | |
CN101843737A (en) | Chinese medicament for treating diabetic feet | |
CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
CN102018765A (en) | Traditional Chinese medicine for treating diabetic acromelic gangrene | |
CN101850055B (en) | Chinese medicament for treating coronary heart diseases | |
CN101843741B (en) | Chinese medicament for treating femoral head necrosis | |
CN101850078B (en) | Chinese medicament for treating chronic nephritis | |
CN101843866A (en) | Chinese medicament for treating diabetic feet | |
CN101843717B (en) | Chinese medicament for treating coronary disease | |
CN101843818B (en) | Chinese medicament for treating chronic nephritis | |
CN101843750B (en) | Chinese medicament for treating chronic nephritis | |
CN101843716B (en) | Chinese medicament for treating femoral head necrosis | |
CN101879259B (en) | Traditional Chinese medicine for treating pulmonary heart diseases | |
CN101843844B (en) | Chinese medicament for treating pulmonary heart diseases | |
CN101884694A (en) | Traditional Chinese medicine for treating diabetic foot | |
CN101843797A (en) | Chinese medicament for treating pulmonary heart diseases | |
CN101843749A (en) | Chinese medicament for treating femoral head necrosis | |
CN101879245A (en) | Traditional Chinese medicine for treating femoral head necrosis | |
CN101843824A (en) | Chinese medicament for treating diabetic feet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20100929 |